ExactAntigen

glial fibrillary acidic protein antibody | antibody review based on formal publications
GFAP antibodies
This is a review about glial fibrillary acidic protein antibodies, based on 60 published articles using glial fibrillary acidic protein antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited glial fibrillary acidic protein antibody.
Sigma-Aldrich    search Sigma-Aldrich GFAP products
icSigma mouse anti-GFAP antibody was used in immunocytochemistry to study the role for hypomorphic Sox2 mutants in impaired generation of mature neurons by neural stem cells in cells from mices. to the paper
ihSigma mouse anti-GFAP antibody was used in pineal sections from rat and in immunohistochemistry to study the role for retinoschisin in rodent and human pineal. to the paper
ihSigma anti-GFAP antibody was used in immunohistochemistry to study the involvement of the thrombin receptor [protease-activated receptor-1 (PAR-1)] in astrogliosis in brain sections from mice'should. to the paper
icSigma-Aldrich anti-GFAP antibody was used in immunocytochemistry to study the role of Ciliary neurotrophic factor (CNTF) to induce the dedifferenciation of adult human myoblasts via p44/p42 MAPK pathway in vitro. to the paper
ihSigma monoclonal anti-GFAP (glial fibrillary acidic protein) antibody was used in immunohistochemistry to identify neurochondrin as a negative regulator for CaMKII phosphorylation. to the paper
ihSigma mouse anti-GFAP was used in immunohistochemistry to detect GFAP in normal and DS human brains. to the paper
icSigma mouse anti-glial fibrillary acidic protein (GFAP) monoclonal antibody was used in immunocytochemistry to provide evidence for the identification of Necl-1 as a neural-tissue-specific Ca2+-independent immunoglobulin-like cell-cell adhesion molecule and its localization at the non-junctional cell-cell contact sites. to the paper
wbSigma anti-GFAP antibody was used in optic nerve and brains sections from mouses and in western blot to study the effect of neuronal Bcl-2 expression and reactive gliosis on the regeneration of RGC axons in vivo. to the paper
wbSigma anti-GFAP antibody was used in western blot to study the interactions between ID and OLIG proteins mediating the inhibitory effects of BMP4 on oligodendroglial differentiation. to the paper
icSigma mouse anti-glial fibrillary acidic protein antibody was used in immunocytochemistry to study citrin and aralar1 are new substrates for the DDP1/TIMM8a–TIMM13 complex. to the paper
ihSigma mouse anti-glial fibrillary acidic protein (GFAP) antibody was used in immunohistochemistry to detect GFAP expression in rat astrocytes and sections of adult rat optic. to the paper
ihSigma mouse monoclonal antibody specific for glial fibrillary acidic protein was used in immunohistochemistry to evaluate the expression of connective tissue growth factor (CTGF) and its fragments in the vitreous of patients with proliferative diabetic retinopathy (PDR). to the paper
icSigma anti-GFAP antibody was used in immunocytochemistry to detect GFAP as glial marker and as a control of the level of protein expression in BdGBM and in BeGBM cells. to the paper
ihSigma-Aldrich GFAP antibody was used in immunohistochemistry to identify an agrin signaling pathway in central nervous system (CNS) neurons. to the paper
ihSigma mouse anti-bovine glial fibrillary acidic protein (GFAP) was used in immunohistochemistry to identify astrocytes in rat brains. to the paper
ih, wbSigma mouse monoclonal anti-GFAP antibody was used in anterior medullary velum from rats and in immunohistochemistry, western blot to study the role for fibroblast growth factor-2 in inducing astroglial and microglial reactivity in vivo. to the paper
icSigma antibody against GFAP (clone GA5) was used in immunocytochemistry to investigate the characterization of mitotic neurons derived from adult rat hypothalamus and brain stem. to the paper
ihSigma rabbit antibody which recognizes glial fibrillary acidic protein (GFAP) was used in immunohistochemistry to study the characterization of two novel nuclear BTB/POZ domain zinc finger isoforms. to the paper
ihSigma polyclonal glial fibrillary acidic protein 19 antibody was used in immunohistochemistry to study the role of respiratory chain deficiency in neurodegeneration and aging in MILON mice. to the paper
ihSigma Cy3-conjugated monoclonal anti-porcine GFAP antibody (Product No. C9205) was used in tissue sections from rats and in immunohistochemistry to study the contribution of myelin to the parallel orientation of neurites. to the paper
ihSigma mouse anti-GFAP antibody(which conjugated to CY3) was used in immunohistochemistry to study the association between inward rectifier potassium channel Kir2.2 and synapse-associated protein SAP97 in rat tissue. to the paper
ihSigma–Aldrich anti-GFAP monoclonal antibody was used in immunohistochemistry to study the distribution of OX2 antigen and OX2 receptor within retina. to the paper
Novus Biologicals    search Novus Biologicals GFAP products
ihNovus Biologicals GFAP antibody was used in immunohistochemistry to demonstrate a possible protective or analgesic effect of GDNF on post-injury neuropathic pain. to the paper
Invitrogen    search Invitrogen GFAP products
icZymed rabbit anti-GFAP antibody was used in immunocytochemistry to study the role for hypomorphic Sox2 mutants in impaired generation of mature neurons by neural stem cells in cells from mices. to the paper
Millipore    search Millipore GFAP products
ih, wbChemicon mouse anti-GFAP antibody was used in protein and paraffin sections from mouses and in western blot, immunohistochemistry to study the role for IGF-I in oligodendrocyte development and myelination. to the paper
ih, wbChemicon mouse monoclonal GFAP antibody was used in western blot and immunohistochemistry to study the role of AQP4 in the transportation of water from blood/CSF to spinal cord parenchyma and vice versa. to the paper
icChemicon GFAP antibody was used in immunocytochemistry to dissect out interactions between the transcription factor Olig2 and other intrinsic and extrinsic factors in neural cell fate determination. to the paper
ic, ip, wbChemicon mouse anti-GFAP monoclonal antibody was used in western blot to detect the expression of GFAP in AxD patient with the RC mutation and in two control brains, in immunocytochemistry to detect GFAP in human primary astrocytes and mouse fibroblasts, and in immunoprecipitation to immunoprecipitate GFAP in mouse fibroblasts. to the paper
ihChemicon antibody against GFAP was used in immunohistochemistry to identify the homologues of the caenorhabditis elegans Fox-1 protein as neuronal splicing regulators in mammals. to the paper
ihChemicon anti-glial fibrillary acidic protein (GFAP) antibody was used in immunohistochemistry to study the relationship of sustained elevation of extracellular dopamine with motor dysfunction and selective degeneration of striatal GABAergic neurons in tissue sections from mice. to the paper
MONOSAN
ihMonosan mouse GFAP antibody was used in immunohistochemistry to study the pathogenetic role of the AQP4 in NMO. to the paper
DAKO
ihDako anti-glial fibrillary acidic protein(GFAP) antibody was used in immunohistochemistry to study whether PGRN genetic variability contributed to other common neurodegenerative brain diseases, such as Alzheimer disease (AD) or Parkinson disease (PD) in sections from human. to the paper
ihDAKO rabbit GFAP antibody was used in immunohistochemistry to study the pathogenetic role of the AQP4 in NMO. to the paper
wbDako GFAP antibody was used in western blot to study the role of AQP4 in the transportation of water from blood/CSF to spinal cord parenchyma and vice versa. to the paper
ihDAKO antibody against glial fibrillar acidic protein was used in immunohistochemistry to detect glial fibrillar acidic protein for the analysis of astrogliosis in mouse brain hemisphere. to the paper
ihDAKO GFAP monoclonal antibody was used in immunohistochemistry to examine the distribution of PLTP in human brain. to the paper
ihDako rabbit polyclonal anti-cow GFAP antibody was used in immunohistochemistry to study the role for astrocytes in orchestrating the recruitment of specific leukocyte subsets to the inflamed CNS and in regulating CNS-targeted immune responses in mice tissue. to the paper
BIOMEDICAL TECHNOLOGIES
ihBiomedical Technologies anti-glial fibrillary acidic protein (GFAP) antibody was used in tissue sections from chick eye (human retinal progenitor cells was transplanted into chick eye) to study the isolation and the characterization of human retinal stem cells. to the paper
NOVOCASTRA
ihNovocastra monoclonal anti-glial fibrillary acidic protein (GFAP) antibody was used in immunohistochemistry to study the impairment of retinoid absorption and storage in mice lacking lecithin:retinol acyltransferase (LRAT). to the paper
IMMUNOSTAR
ihImmunoStar rabbit polyclonal anti-glial fibrilliary acidic protein (GFAP) antibody(which recognizes astrocytes) was used in immunohistochemistry to study the role for delivery of neurotrophin-3 from fibrin in neuronal fiber sprouting after spinal cord injury in tissue sections from rats. to the paper
DAKO IMMUNOCHEMICALS
icDako Immunochemicals antibody against GFAP was used in immunocytochemistry to investigate the characterization of mitotic neurons derived from adult rat hypothalamus and brain stem. to the paper
PROGEN
ihProgen mouse anti-GFAP monoclonal antibody was used in immunohistochemistry to study the protective role of phosphorylation in turnover of glial fibrillary acidic protein in mice. to the paper
LAB VISION
wbLab Vision GFAP (Glial Fibrillary Acidic Protein) Ab-1 antibody was tested in western blot by Abminer . to the paper
DAKO
icDAKO rabbit anti-GFAP antibody was used in rat cells and in immunocytochemistry to study the differentiation of adherently expandable neural stem (NS) cells. to the paper
ihDakoCytomation GFAP antibody was tested in immunohistochemistry by HPA (CAB000039) . to the paper
ihDAKO rabbit polyclonal anti-glial fibrillary acidic protein antibody was used in tissue from mouse and in immunohistochemistry to study the safe imaging technique aimed at quantifying CNS myelin. to the paper
ihDAKO rabbit antibody against GFAP was used in immunohistochemistry to stain for GFAP-positive astrocytes from rat neonatal cortices. to the paper
ihDAKO monoclonal anti-human glial fibrillary acidic protein antibody was used in immunohistochemistry to study Kv1.3 expression on inflammatory infiltrates in multiple sclerosis brain. to the paper
ihDako A/S rabbit anti-bovine GFAP (1:1000) was used in immunohistochemistry to study the changes of retinal gene expression in proliferative vitreoretinopathy. to the paper
wbDAKO anti-GFAP antibody was used in western blot to study the relationship between FPR expression and the biologic behavior of glioma cells. to the paper
ic, wbDAKO polyclonal anti-glial fibrillary acidic protein (GFAP) antibody was used in western blot and immunocytochemistry to study the characterization of Novel Phospholipase C (PLC 2). to the paper
ihDAKO rabbit anti-GFAP antibody was used in immunohistochemistry to study the inducing of platelet-derived growth factor C to liver fibrosis, steatosis, and hepatocellular carcinoma. to the paper
ihDako monoclonal anti-glial fibrillary acidic protein (GFAP) antibody was used in immunohistochemistry to study cathepsin S expression in human astrocytomas. to the paper
ihDAKO polyclonal anti-GFAP antibody was used in paraffin sections from human tumor and in immunohistochemistry to study the expression of synuclein in glial tumors and medulloblastomas. to the paper
ihDako rabbit anti-GFAP antibody was used in immunohistochemistry to test the hypothesis that glioma cells exploit their astrocyte environment for MMP-2 production and activation and that the consequence of this interaction is the increased ability of glioma cells to invade. to the paper
ihDAKO anti-glial fibrillary acidic protein (GFAP) antibody was used in immunohistochemistry to study ceruloplasmin expresion in the retina after photic injury. to the paper
ihDAKO rabbit-anti-GFAP antiserum was used in immunohistochemistry to study teh binding of soluble dimeric prion protein with PrPSc in vivo. to the paper
ihDAKO mouse monoclonal anti–glial fibrillary acidic protein antibody was used in immunohistochemistry to study neuronal apolipoprotein E expressionin in human brain with cerebral infarction. to the paper
ic Dako anti-GFAP antibody was used in immunocytochemistry to study alpha-1, 3-fucosyltransferase IX (Fut9) to determine Lewis X expression in brain. to the paper
ihDako anti-GFAP antibody was used in immunohistochemistry to study LIMP-2-deficient mice. to the paper
ihDako anti-GFAP polyclonal antibody was used in immunohistochemistry to study the gastrulation arrest and cell cycle inhibition caused by Rnf2 (Ring1b) deficiency. to the paper
icDako anti-GFAP antibody was used in immunocytochemistry to study the protective role of phosphorylation in turnover of glial fibrillary acidic protein in mice. to the paper
ihDako anti-GFAP antibody was used in immunohistochemistry to study the widespread neuronal intranuclear inclusions in SCA2 at genetic, morphological and immunohistochemical levels. to the paper
icDako monoclonal anti-GFAP antibody (clone 6F2) was used in primary human glioma cell and in immunocytochemistry to study the role for targeted AdV in cancer gene therapy. to the paper
icDako rabbit polyclonal anti-glial fibrillary acidic protein (astrocytes, and reactive Müller cells) antibody was used in immunocytochemistry to study the function of nuclear receptor NR2E3 in human retinal photoreceptor differentiation and degeneration. to the paper
Articles Reviewed
1:Maurizio Cavallaro et al. Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants. 2008
2:T Glaser et al. Tripotential differentiation of adherently expandable neural stem (NS) cells.. 2007
3:T Misu et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. 2007
4:Nathalie Brouwers et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. 2007
5:Martha Zeger et al. Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination. 2007
6:Yuichiro Takada et al. Retinoschisin expression and localization in rodent and human pineal and consequences of mouse RS1 gene knockout. 2006
7:Sara J Taylor et al. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. 2006
8:Melissa Y Macias et al. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. 2006
9:Tarja Malm et al. beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits. 2006
10:Bruno Stankoff et al. Imaging of CNS myelin by positron-emission tomography. 2006
11:Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006
12:Anja Persson et al. A human protein atlas based on antibody proteomics. 2006
13:Rujin Tian et al. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. 2006
14:Zhong-Wei Du et al. Induced expression of Olig2 is sufficient for oligodendrocyte specification but not for motoneuron specification and astrocyte repression. 2006
15:O Nesic et al. Acute and chronic changes in aquaporin 4 expression after spinal cord injury. 2006
16:Jennifer Chen et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. 2005
17:Xiaoping Chen et al. Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. 2005
18:Masamichi Nakahara et al. A novel phospholipase C, PLC(eta)2, is a neuron-specific isozyme. 2005
19:Horea Rus et al. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. 2005
20:Nuttaporn Wongsiriroj et al. Retinoid absorption and storage is impaired in mice lacking lecithin:retinol acyltransferase (LRAT). 2005
21:Shigeki Kakunaga et al. Nectin-like molecule-1/TSLL1/SynCAM3: a neural tissue-specific immunoglobulin-like cell-cell adhesion molecule localizing at non-junctional contact sites of presynaptic nerve terminals, axons and glia cell processes. 2005
22:Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005
23:Pablo Helguera et al. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. 2005
24:Jason G Underwood et al. Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. 2005
25:Jean S Campbell et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. 2005
26:Minori Dateki et al. Neurochondrin negatively regulates CaMKII phosphorylation, and nervous system-specific gene disruption results in epileptic seizure. 2005
27:Margrit Hollborn et al. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. 2005
28:Kin-Sang Cho et al. Re-establishing the regenerative potential of central nervous system axons in postnatal mice. 2005
29:Olivier Nicole et al. Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. 2005
30:Amanpreet S Kalsi et al. Kir4.1 expression by astrocytes and oligodendrocytes in CNS white matter: a developmental study in the rat optic nerve. 2004
31:Brenda L K Coles et al. Facile isolation and the characterization of human retinal stem cells. 2004
32:David R Hinton et al. Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy. 2004
33:Karin Roesch et al. The calcium-binding aspartate/glutamate carriers, citrin and aralar1, are new substrates for the DDP1/TIMM8a-TIMM13 complex. 2004
34:Jayshree Samanta et al. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. 2004
35:Pierre-François Cartron et al. Nonredundant role of Bax and Bak in Bid-mediated apoptosis. 2003
36:Philipp Meier et al. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. 2003
37:Jan Willem Voncken et al. Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. 2003
38:Michel Cyr et al. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. 2003
39:Shoko Nishihara et al. Alpha1,3-fucosyltransferase IX (Fut9) determines Lewis X expression in brain. 2003
40:Cameron L Hoover et al. The COOH-terminal domain of agrin signals via a synaptic receptor in central nervous system neurons. 2003
41:Duc M Le et al. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. 2003
42:Lin Chen et al. Increased expression of ceruloplasmin in the retina following photic injury. 2003
43:Kazuko Aoki et al. Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. 2003
44:Simona Vuletic et al. Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease. 2003
45:Elena Ambrosini et al. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. 2003
46:Thomas Flannery et al. The clinical significance of cathepsin S expression in human astrocytomas. 2003
47:Alexander-Christian Gamp et al. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. 2003
48:Kar-Ming Fung et al. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas. 2003
49:Joanna T Pang et al. Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases. 2002
50:Rita M Cowell et al. Hypoxic-ischemic injury induces macrophage inflammatory protein-1alpha expression in immature rat brain. 2002
51:Masaaki Takemura et al. Protective role of phosphorylation in turnover of glial fibrillary acidic protein in mice. 2002
52:Diane R Goddard et al. Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo. 2002
53:Victor W van Beusechem et al. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished. 2002
54:Cathy Mitchelmore et al. Characterization of two novel nuclear BTB/POZ domain zinc finger isoforms. Association with differentiation of hippocampal neurons, cerebellar granule cells, and macroglia. 2002
55:Ann H Milam et al. The nuclear receptor NR2E3 plays a role in human retinal photoreceptor differentiation and degeneration. 2002
56:Jenafer Evans et al. Characterization of mitotic neurons derived from adult rat hypothalamus and brain stem. 2002
57:DB Pettigrew et al. Myelin contributes to the parallel orientation of axonal growth on white matter in vitro.. 2001
58:A D Dick et al. Distribution of OX2 antigen and OX2 receptor within retina. 2001
59:D Leonoudakis et al. Inward rectifier potassium channel Kir2.2 is associated with synapse-associated protein SAP97. 2001
60:L Sörensen et al. Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. 2001


2008©ExactAntigen home | browse | about